Latest News

April 10, 2018

Analgesic Solutions to Present Posters at Five Conferences in 2018

By asoladmin In Uncategorized with Comments Off on Analgesic Solutions to Present Posters at Five Conferences in 2018

 

Analgesic Solutions will present proprietary tools and research posters at five conferences in 2018. We invite you to meet our team presenting the following research posters.

If you would like to schedule a meeting at any of the conferences or would like to learn more about the information being presenting, please contact Tony May at tmay@analgesicsolutions.com or 781-444-9605 x120.


Poster Presentations

April 2018

  • American Academy of Pain (Vancouver, Canada):

“Assessment of a Systematic Framework to Determine the Equianalgesic Conversion Ratio Between Opioids: Determining the Conversion Ratio Between Tapentadol and Morphine”

June 2018

  • College of Problems of Drug Dependence (San Diego, CA): 

“Nektar: Phase 3, Double-Blind, Placebo Controlled Study to Assess the Efficacy, Safety, and Tolerability of NKTR-181 in Opioid-Naïve Subjects with Moderate to Severe Chronic Low Back Pain”

“Assessment of Drug-Abuse Related Events with MADDERS in SUMMIT-07: A Phase-3 Study of NKTR-181 in Patients with Moderate to Severe Chronic Low-Back Pain”

  • DIA 2018 Global Annual Meeting (Boston, MA): 

“MADDERS: A Systematic Approach to Meeting Regulatory Requirements for Evaluating Abuse-Related Events in Clinical Trials”

“Placebo Response Reduction Training in Chronic Low Back Pain: Comparison to Other Published Studies on Chronic Low Back Pain”

September 2018

  • IASP World Congress on Pain (Boston, MA):

Posters TBD

October 2018

  • Pain and Migraine Therapeutics Summit (San Francisco, CA):

Posters TBD


Analgesic Solutions, LLC, founded in 2006, is a privately held company focused on increasing assay sensitivity in the conduct of pain clinical trials through consulting, innovative tools and technology, and training. Our team, with Nathaniel Katz M.D., M.S., serving as our foremost expert, helps clients develop and commercialize better treatments for pain. With hundreds of projects completed and ongoing collaborations with regulatory authorities, Analgesic Solutions is the expert at identifying and mitigating the random and systematic errors that lead to negative clinical trials.

Scroll to top